Open access · CC-BY
via OpenAlex
Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
Md. Habibur Rahman, Rokeya Akter, Tanima Bhattacharya, Mohamed M. Abdel‐Daim, Saad Hussin Alkahtani, Mohammed Waleed Arafah, Norah S. AL–Johani, Norah M. Alhoshani, Nora Alkeraishan, Alhanof Alhenaky, Omar Hamed Abd-Elkader, Hesham Rushdey El-Seedi, Deepak Kumar Kaushik, Vineet Mittal
Frontiers in Pharmacology · 2020 · ▲ 195 citations
Abstract
Alzheimer’s disease (AD) is a progressive cortex and hippocampal neurodegenerative disease which ultimately causes cognitively impaired decline in patients. The AD pathogen is a very complex process, including aggregation of Aβ (β-amyloid peptides), phosphorylation of tau-proteins, and chronic inflammation. Exactly, resveratrol, a polyphenol present in red wine, and many plants are indicated to show the neuroprotective effect on mechanisms mostly above. Resveratrol plays an important role in promotion of non-amyloidogenic cleavage of the amyloid precursor protein. It also enhances the clearance of amyloid beta-peptides and reduces the damage of neurons. Most experimental research on AD and resveratrol has been performed in many species, both in vitro and in vivo , during the last few years. Nevertheless, resveratrol’s effects are restricted by its bioavailability in the reservoir. Therefore, scientists have tried to improve its efficiency by using different methods. This review focuses on recent work done on the cell and animal cultures and also focuses on the neuroprotective molecular mechanisms of resveratrol. It also discusses about the therapeutic potential onto the treatment of AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fphar.2020.619024
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Rahman, M.H., Akter, R., Bhattacharya, T., Abdel‐Daim, M.M., Alkahtani, S.H., Arafah, M.W., AL–Johani, N.S., Alhoshani, N.M., Alkeraishan, N., Alhenaky, A., Abd-Elkader, O.H., El-Seedi, H.R., Kaushik, D.K., & Mittal, V. (2020). Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease. <em>Frontiers in Pharmacology</em>. https://doi.org/10.3389/fphar.2020.619024
Vancouver
Rahman MH, Akter R, Bhattacharya T, Abdel‐Daim MM, Alkahtani SH, Arafah MW, et al. Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease. Frontiers in Pharmacology. 2020. doi:10.3389/fphar.2020.619024.
BibTeX
@article{md2020Resver,
title = {Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease},
author = {Md. Habibur Rahman and Rokeya Akter and Tanima Bhattacharya and Mohamed M. Abdel‐Daim and Saad Hussin Alkahtani and Mohammed Waleed Arafah and Norah S. AL–Johani and Norah M. Alhoshani and Nora Alkeraishan and Alhanof Alhenaky and Omar Hamed Abd-Elkader and Hesham Rushdey El-Seedi and Deepak Kumar Kaushik and Vineet Mittal},
journal = {Frontiers in Pharmacology},
year = {2020},
doi = {10.3389/fphar.2020.619024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BioMed Research International 2014
Open access · CC-BY
Resveratrol as a Therapeutic Agent for Alzheimer’s Disease
Diabetes Obesity and Metabolism 2026
Open access · OA
Amino acid metabolism modulates chronic kidney disease progression by mediating the aging process: Mechanistic insights and therapeutic interventions
Journal of Parkinson s Disease 2013
Open access · OA
The Role of Oxidative Stress in Parkinson's Disease
Journal of Neuroscience Research 2002
Open access · OA
Role of mitochondrial dysfunction in Alzheimer's disease
Brain 2006
Open access · OA
Therapeutic approaches to Alzheimer's disease
Translational Neurodegeneration 2022
Open access · CC-BY